XULTOPHY

Google image searchProduct monograph

Active ingredients

insulin degludec, 100 UNIT/ML

liraglutide, 3.6 MG/ML

DIN: 02474875

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PRE-FILLED PEN

Schedule: Prescription / Schedule D

Company: NOVO NORDISK CANADA INC

Date: 06-JUN-2018

ATC:

• A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
• A10A — INSULINS AND ANALOGUES (ATC, ATC/DDD)
• A10AE — Insulins and analogues for injection, long-acting (ATC, ATC/DDD)
• A10AE56 — INSULIN DEGLUDEC AND LIRAGLUTIDE (ATC/DDD)

Reference brand drug: Xultophy

External Links for Xultophy

Search on Google

• Xultophy side effects
• Xultophy dosage
• insulin degludec side effects
• insulin degludec dosage
• liraglutide side effects
• liraglutide dosage

Novo Nordisk Canada Inc

Go to Novo Nordisk website to see drug product details. Sometimes you can find xultophy photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.